AI Analysis

How does PAR.NS make money? Does PAR.NS have pricing power? What's the Earnings Whisper? Will PAR.NS profit more as the business scales? What is PAR.NS's management track record? Is PAR.NS's current price justified?

Par Drugs and Chemicals Limited

₹109.53 +$7.85 (+7.72%)

NSE · 16 Oct 2026 09:50 UTC

Previous Close

₹111.22

Day Range

₹108₹112.79

Year Range

₹78.05₹180

Market Cap

1.35B

AVG Volume

55.35K

Trailing/Forward PE

9.3/-

PEG ratio

3.82

Dividend Yield

Next Earnings Date

Primary Exchange

National Stock Exchange of India

Revenue (INR) · Q

PAR.NS Revenue (INR) by quarter
Period	Revenue (INR)
27 Q1	312.81M
26 Q4	196.11M
26 Q3	293.39M
26 Q2	286.59M
26 Q1	260.46M
25 Q4	223.3M
25 Q3	213.81M
25 Q2	346.57M
25 Q1	226.06M
24 Q4	228.19M

Net Income (INR) · Q

PAR.NS Net Income (INR) by quarter
Period	Net Income (INR)
27 Q1	47.13M
26 Q4	8.54M
26 Q3	47.97M
26 Q2	41.3M
26 Q1	33.28M
25 Q4	16.51M
25 Q3	5.78M
25 Q2	85.96M
25 Q1	25.33M
24 Q4	37.19M

Operating Income (INR) · Q

PAR.NS Operating Income (INR) by quarter
Period	Operating Income (INR)
27 Q1	54.16M
26 Q4	5.14M
26 Q3	51.31M
26 Q2	51.25M
26 Q1	26.57M
25 Q4	15.09M
25 Q3	5.15M
25 Q2	105M
25 Q1	33.31M
24 Q4	52.02M

EBITDA · Q

Cash Flows · Q

EPS · Q

Expenses · Q

Cash & Debt · Q

Debt ratios · Q

Margins · Q

Return on Capital · Q

Shares Outstanding · Q

Dividends (INR) · Q

Employee Count

Book Value Per Share · Q

Total Assets · Q

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

Par Drugs and Chemicals Limited

Video analysis: PAR.NS

News: PAR.NS

Similar companies